CLX
NYSE · USDOne year, rebased to 100
CLX SPY XLP (sector ETF) · weekly closesScore DNA
Each bar is a 0-100 score within the scored universeFlags
Smart-money strip
Each disclosure source on its own window. Filings coinciding is not coordination.Key financials · FY2026
USD, fiscal year. Stock-based compensation is non-cash; shown against FCF.Valuation
CLX vs industry median
112 companies in Household & Personal ProductsEarnings delivery
Next report 2026-11-02 · consensus EPS $1.08Peers
Market-cap band, not the industry cohort above| Company | Mkt cap | P/E | ROE | Net margin | Rev growth | 12m return |
|---|---|---|---|---|---|---|
| CLX The Clorox Company | $10.5B | 18.1x | -1,893.5% | 8.7% | −5.4% | −22.5% |
| ELF e.l.f. Beauty, Inc. | $6.7B | 113.4x | 6.0% | 13.9% | +31.2% | −16.4% |
| REYN Reynolds Consumer Products I | $4.8B | 13.9x | 15.5% | 9.4% | +2.7% | −2.0% |
| CHD Church & Dwight Co., Inc. | $24.8B | 33.5x | 17.0% | 13.3% | +2.7% | +21.4% |
| IPAR Inter Parfums, Inc. | $3.7B | 22.1x | 19.6% | 8.9% | +2.9% | +24.6% |
| KMB Kimberly-Clark Corporation | $35.1B | 18.0x | 129.4% | 8.2% | −12.3% | — |
| KVUE Kenvue Inc. | $36.3B | 21.7x | 15.6% | 11.5% | +1.8% | — |
| EL The Estée Lauder Companies | $37.9B | 205.0x | 4.7% | -3.2% | +5.1% | — |
Recent 8-K filings
Context
Full factsheet
The PDF carries everything on this page plus the cash-allocation waterfall, Form 144 notices, 13F holder detail, dark-pool and short-flow history, seasonality and the moat assessment (Weak).
Read it in the browser Download (PDF)All fundamentals · 140 measures in 13 categories
Percentile = where CLX sits among 20 scored companies in Household & Personal Products (0 = lowest value, 100 = highest). It is a position, not a grade.Valuation
| Measure | CLX | Industry percentile |
|---|---|---|
| P/E (TTM) | 17.9x | 9th |
| PEG (P/E ÷ 3-yr EPS CAGR) | 0.30 | 0th |
| Price / sales | 1.6x | 37th |
| Price / book | 117.0x | 95th |
| Price / tangible book | — | |
| Price / free cash flow | 26.0x | 94th |
| Price / operating cash flow | 17.2x | 75th |
| Enterprise value | $15.9B | 68th |
| EV / sales | 2.4x | 53rd |
| EV / EBITDA | 13.6x | 31st |
| EV / EBIT | 17.3x | 36th |
| EV / free cash flow | 39.3x | 88th |
| Earnings yield | 5.6% | 95th |
| FCF yield | 3.8% | 21st |
| Operating cash flow yield | 5.8% | 37th |
| Graham number (per share) | $8.93 | 18th |
Profitability (TTM)
| Measure | CLX | Industry percentile |
|---|---|---|
| Gross margin | 42.3% | 37th |
| EBITDA margin | 17.4% | 68th |
| Operating margin | 24.7% | 100th |
| EBIT margin | 13.7% | 68th |
| Net margin | 8.7% | 63rd |
| NOPAT margin | 18.8% | 100th |
| FCF margin | 6.0% | 37th |
| Operating cash flow margin | 9.1% | 32nd |
| R&D / revenue | 1.7% | 79th |
| SG&A / revenue | 15.9% | 11th |
| Stock comp / revenue | 0.7% | 39th |
| Effective tax rate | 24.0% | 68th |
Returns on capital
| Measure | CLX | Industry percentile |
|---|---|---|
| ROE (on average equity) | 285.6% | 95th |
| ROA | 8.8% | 79th |
| ROIC | 23.1% | 79th |
| ROCE | 18.3% | 79th |
| Return on tangible assets | 13.8% | 79th |
| Cash ROIC (OCF / invested capital) | 11.2% | 29th |
| Gross profitability (GP / assets) | 36.5% | 53rd |
| ROIC, 3-yr average | 16.5% | 76th |
| ROIC, 5-yr average | 15.1% | 71st |
| ROE, 5-yr average | 228.1% | 100th |
| Incremental ROIC | 26.9% | 79th |
Growth
| Measure | CLX | Industry percentile |
|---|---|---|
| Revenue growth (TTM YoY) | -5.4% | 21st |
| Revenue growth (QoQ) | 16.6% | 84th |
| Revenue CAGR, 3 yr | -3.1% | 22nd |
| Revenue CAGR, 5 yr | -1.8% | 27th |
| Gross profit CAGR, 3 yr | -0.7% | 17th |
| Operating income CAGR, 3 yr | 24.7% | 92nd |
| Net income growth (TTM YoY) | -27.5% | 30th |
| Net income CAGR, 3 yr | 57.9% | 100th |
| EPS growth (TTM YoY) | -26.6% | 30th |
| EPS CAGR, 3 yr | 59.0% | 100th |
| EPS CAGR, 5 yr | -3.2% | 33rd |
| FCF growth (TTM YoY) | -46.8% | 0th |
| FCF CAGR, 3 yr | -24.2% | 15th |
| Operating cash flow CAGR, 3 yr | -19.1% | 7th |
| Book value CAGR, 3 yr | -25.3% | 12th |
| Dividend CAGR, 3 yr | 0.7% | 33rd |
| Sustainable growth rate | -7.3% | 9th |
Margin history & stability
| Measure | CLX | Industry percentile |
|---|---|---|
| Gross margin, 3-yr average | 43.4% | 37th |
| Operating margin, 3-yr average | 18.2% | 89th |
| Net margin, 3-yr average | 8.0% | 58th |
| FCF margin, 3-yr average | 7.8% | 58th |
| Revenue stability (0-1) | 0.72 | 53rd |
| Earnings stability (0-1) | 0.01 | 11th |
| Margin stability (0-1) | 0.95 | 42nd |
Liquidity (latest quarter)
| Measure | CLX | Industry percentile |
|---|---|---|
| Cash & short-term investments | $143.0M | 26th |
| Net cash (− = net debt) | −$5.4B | 26th |
| Working capital | −$949.0M | 5th |
| Current ratio | 0.66 | 0th |
| Quick ratio | 0.38 | 0th |
| Cash ratio (cash + ST investments / current liabilities) | 0.05 | 5th |
| Defensive interval (days) | 288 days | 68th |
Leverage & solvency (latest quarter)
| Measure | CLX | Industry percentile |
|---|---|---|
| Total debt | $5.5B | 68th |
| Debt / equity | 61.33 | 100th |
| Net debt / equity | 59.74 | 100th |
| Debt / assets | 70.8% | 100th |
| Debt / capital | 98.4% | 100th |
| Debt / EBITDA | 4.73 | 56th |
| Net debt / EBITDA | 4.60 | 62nd |
| Interest coverage (EBIT / interest) | 7.1x | 61st |
| Cash interest coverage | 4.7x | 39th |
| Debt payback (years of OCF) | 9.0 yrs | 81st |
| Liabilities / assets | 96.8% | 100th |
| IS credit model rating | BB | |
| Implied credit spread (bps) | 475 | 58th |
Efficiency
| Measure | CLX | Industry percentile |
|---|---|---|
| Asset turnover | 1.01 | 89th |
| Fixed asset turnover | 3.51 | 22nd |
| Inventory turnover | 6.0 | 89th |
| Receivables turnover | 8.4 | 37th |
| Days sales outstanding | 43 days | 63rd |
| Days inventory outstanding | 61 days | 11th |
| Days payables outstanding | 115 days | 68th |
| Cash conversion cycle (days) | −10 days | 16th |
| Capex / revenue | 3.1% | 71st |
| Capex / depreciation | 0.84 | 71st |
| Operating expense ratio | — |
Cash flow & earnings quality
| Measure | CLX | Industry percentile |
|---|---|---|
| Operating cash flow / net income | 1.04 | 9th |
| FCF / net income | 0.69 | 9th |
| FCF / operating cash flow | 66.2% | 31st |
| Capex / operating cash flow | 33.8% | 69th |
| Accruals ratio | -0.4% | 95th |
| Sloan accruals ratio | -13.3% | 5th |
| Earnings quality score (0-1) | 1.00 | 73rd |
Scores & forensic checks
| Measure | CLX | Industry percentile |
|---|---|---|
| IS score | 40 | 42nd |
| IS profitability | 68 | 89th |
| IS growth | 41 | 26th |
| IS value | 49 | 63rd |
| IS momentum | 45 | 21st |
| IS risk (safety) | 50 | 32nd |
| IS quality | 50 | 42nd |
| IS balance sheet | 25 | 21st |
| IS earnings quality | 82 | 89th |
| IS cash flow | 34 | 21st |
| Piotroski F-score (0-9) | 4 | 5th |
| Altman Z-score | 2.1 | 32nd |
| Beneish M-score | −2.01 | 95th |
| Ohlson O-score | −4.71 | 89th |
| IS credit score | 41 | 32nd |
Size (TTM)
| Measure | CLX | Industry percentile |
|---|---|---|
| Market cap | $10.5B | 68th |
| Revenue | $6.7B | 68th |
| EBITDA | $1.2B | 68th |
| Net income | $587.0M | 74th |
| Free cash flow | $405.0M | 68th |
| Total assets | $7.8B | 58th |
| Shareholders' equity | $90.0M | 0th |
| Employees | 9,200 | 63rd |
Insider transactions, last 6 months
Form 4 · most recent 12| Date | Insider | Type | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-10-05 | Rendle Linda J Director, Chief Executive Officer |
Award / grant | 29,352 | $80.41 | $2.4M | 282,488 |
| 2026-10-05 | Rendle Linda J Director, Chief Executive Officer |
Tax withholding | 692 | $80.41 | $55,644 | 281,796 |
| 2026-10-05 | Rendle Linda J Director, Chief Executive Officer |
Tax withholding | 11,989 | $80.41 | $964,035 | 269,807 |
| 2026-10-05 | Peck Laurene E VP - CAO & Corp Controller |
Award / grant | 1,172 | $80.41 | $94,241 | 10,386 |
| 2026-10-05 | Peck Laurene E VP - CAO & Corp Controller |
Tax withholding | 30 | $80.41 | $2,412 | 10,356 |
| 2026-10-05 | Peck Laurene E VP - CAO & Corp Controller |
Tax withholding | 339 | $80.41 | $27,259 | 10,017 |
| 2026-10-05 | Marriner Kirsten EVP - Chief Admin Officer |
Award / grant | 6,637 | $80.41 | $533,681 | 83,591 |
| 2026-10-05 | Marriner Kirsten EVP - Chief Admin Officer |
Tax withholding | 1,951 | $80.41 | $156,880 | 81,640 |
| 2026-10-05 | Marriner Kirsten EVP - Chief Admin Officer |
Tax withholding | 2,142 | $80.41 | $172,238 | 79,498 |
| 2026-10-05 | Hyder Chris T EVP-Chief Operating Officer |
Award / grant | 4,191 | $80.41 | $336,998 | 94,618 |
| 2026-10-05 | Hyder Chris T EVP-Chief Operating Officer |
Tax withholding | 100 | $80.41 | $8,041 | 94,518 |
| 2026-10-05 | Hyder Chris T EVP-Chief Operating Officer |
Tax withholding | 1,532 | $80.41 | $123,188 | 92,986 |
Shares acquired vs disposed, by month
acquired disposed · all Form 4 typesBy transaction type, 6 months
| Type | Direction | Filings | Shares | Value |
|---|---|---|---|---|
| Award / grant | Acquired | 37 | 305,381 | $26.5M |
| Open-market buy | Acquired | 1 | 5,000 | $429,124 |
| Tax withholding | Disposed | 15 | 28,097 | $2.3M |
Form 144 notices
| Filed | Filer | Shares proposed | Est. proceeds |
|---|---|---|---|
| 2025-09-04 | Eric Reynolds | 15,041 | $1.9M |
| 2025-03-10 | Marriner Kirsten | 8,227 | $1.3M |
| 2024-12-16 | Hilt Angela C | 1,248 | $205,820 |
| 2024-09-06 | Hilt Angela C | 1,733 | $285,980 |
Congress trades
12 months: House 13 trades (4 purchases) · Senate 0 (0 purchases)| Traded | Member | Chamber | Type | Amount | Disclosed |
|---|---|---|---|---|---|
| 2026-05-15 | Gilbert Cisneros | House | Sale | $1,001 - $15,000 | 2026-06-09 |
| 2026-05-15 | Gilbert Cisneros | House | Sale (Full) | $1,001 - $15,000 | 2026-06-09 |
| 2026-05-14 | Gilbert Ray Cisneros | House | Sale (Full) | $1,001 - $15,000 | 2026-06-09 |
| 2026-01-29 | Ro Khanna | House | Sale | $1,001 - $15,000 | 2026-02-10 |
| 2024-04-29 | Tommy Tuberville | Senate | Purchase | $1,001 - $15,000 | 2024-05-15 |
| 2024-04-29 | Tommy Tuberville | Senate | Purchase | $1,001 - $15,000 | 2024-05-14 |
| 2024-04-29 | Thomas Hawley Tuberville | Senate | Purchase | $1,001 - $15,000 | 2024-05-14 |
| 2023-10-31 | Tommy Tuberville | Senate | Sale (Partial) | $100,001 - $250,000 | 2023-11-16 |
Largest 13F holders
Quarter to 2026-06-30, the latest most managers have filed| Manager | Shares | Value | % of shares out |
|---|---|---|---|
| BlackRock, Inc. | 10,044,423 | $958.6M | 8.31% |
| STATE STREET CORP | 8,432,523 | $804.8M | 6.97% |
| VANGUARD CAPITAL MANAGEMENT LLC | 7,896,390 | $753.6M | 6.53% |
| Invesco Ltd. | 6,010,072 | $573.6M | 4.97% |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 5,799,952 | $553.5M | 4.80% |
| GEODE CAPITAL MANAGEMENT, LLC | 3,265,551 | $310.4M | 2.70% |
| VAN ECK ASSOCIATES CORP | 2,972,952 | $283.7M | 2.46% |
| UBS Group AG | 1,978,411 | $188.8M | 1.64% |
| BANK OF AMERICA CORP /DE/ | 1,883,700 | $179.8M | 1.56% |
| CITADEL ADVISORS LLC | 1,765,044 | $168.5M | 1.46% |
| ProShare Advisors LLC | 1,635,159 | $156.1M | 1.35% |
| Bank of New York Mellon Corp | 1,267,381 | $121.0M | 1.05% |
| CONFLUENCE INVESTMENT MANAGEMENT LLC | 1,247,644 | $119.1M | 1.03% |
| DIMENSIONAL FUND ADVISORS LP | 1,203,658 | $114.9M | 1.00% |
| NORTHERN TRUST CORP | 1,188,239 | $113.4M | 0.98% |
Institutional ownership by quarter
Holder changes by quarter
| Quarter | Holders | Ownership | New | Increased | Reduced | Closed |
|---|---|---|---|---|---|---|
| 2026-06-30 | 1,056 | 86.5% | 138 | 406 | 360 | 159 |
| 2026-03-31 | 1,092 | 82.4% | 169 | 410 | 316 | 111 |
| 2025-12-31 | 1,055 | 81.8% | 162 | 301 | 437 | 171 |
| 2025-09-30 | 1,094 | 85.2% | 117 | 376 | 408 | 135 |
| 2025-06-30 | 1,130 | 89.6% | 103 | 401 | 427 | 152 |
| 2025-03-31 | 1,191 | 83.1% | 116 | 421 | 412 | 135 |
| 2024-12-31 | 1,227 | 82.5% | 171 | 405 | 393 | 77 |
| 2024-09-30 | 1,157 | 81.6% | 145 | 344 | 435 | 72 |
| 2024-06-30 | 1,096 | 83.5% | 97 | 402 | 386 | 131 |
| 2024-03-31 | 1,150 | 82.0% | 136 | 370 | 402 | 83 |
| 2023-12-31 | 1,112 | 81.3% | 156 | 302 | 450 | 99 |
| 2023-09-30 | 1,068 | 81.7% | 85 | 385 | 386 | 147 |
Schedule 13D / 13G filers
| Filed | Form | Filer | % of class | Shares |
|---|---|---|---|---|
| 2026-04-29 | SCHEDULE 13G | Vanguard Capital Management | 7.3% | 8,889,552 |
| 2026-03-26 | SCHEDULE 13G/A | The Vanguard Group | 0.0% | 0 |
| 2025-07-17 | SCHEDULE 13G/A | BlackRock, Inc. | 8.1% | 9,954,343 |
| 2025-04-25 | SCHEDULE 13G/A | UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC | 0.9% | 1,081,801 |
ETFs with the largest holding
| ETF | Weight in fund | Holding value |
|---|---|---|
| VITSX | 0.01% | $312.0M |
| VTI | 0.01% | $312.0M |
| VTSAX | 0.01% | $312.0M |
| VSMPX | 0.01% | $312.0M |
| VFFSX | 0.01% | $257.3M |
| VFIAX | 0.01% | $257.3M |
Share structure
Income statement
Fiscal years, USD| FY2022 | FY2023 | FY2024 | FY2025 | FY2026 | |
|---|---|---|---|---|---|
| Revenue | $7.1B | $7.4B | $7.1B | $7.1B | $6.7B |
| Cost of revenue | $4.6B | $4.5B | $4.1B | $3.9B | $3.9B |
| Gross profit | $2.5B | $2.9B | $3.0B | $3.2B | $2.8B |
| R&D | $132.0M | $138.0M | $126.0M | $121.0M | $116.0M |
| SG&A | $1.7B | $1.9B | $2.0B | $1.9B | $1.1B |
| Operating income | $696.0M | $827.0M | $916.0M | $1.2B | $1.7B |
| EBITDA | $928.0M | $577.0M | $736.0M | $1.4B | $1.2B |
| Pretax income | $607.0M | $238.0M | $398.0M | $1.1B | $791.0M |
| Income tax | $136.0M | $77.0M | $106.0M | $254.0M | $190.0M |
| Net income | $462.0M | $149.0M | $280.0M | $810.0M | $587.0M |
| EPS, diluted | $3.73 | $1.20 | $2.25 | $6.52 | $4.81 |
| Diluted shares | 123.9M | 124.2M | 124.8M | 124.3M | 122.1M |
Balance sheet
| FY2022 | FY2023 | FY2024 | FY2025 | FY2026 | |
|---|---|---|---|---|---|
| Cash & short-term investments | $183.0M | $367.0M | $202.0M | $167.0M | $143.0M |
| Receivables | $681.0M | $688.0M | $695.0M | $821.0M | $791.0M |
| Inventory | $755.0M | $696.0M | $637.0M | $523.0M | $777.0M |
| Total current assets | $1.7B | $1.8B | $1.6B | $1.6B | $1.8B |
| PP&E, net | $1.7B | $1.7B | $1.7B | $1.6B | $1.9B |
| Goodwill & intangibles | $2.4B | $2.0B | $1.9B | $1.8B | $2.6B |
| Total assets | $6.2B | $5.9B | $5.8B | $5.6B | $7.8B |
| Accounts payable | $960.0M | $1.0B | $950.0M | $838.0M | $1.6B |
| Total current liabilities | $1.8B | $1.9B | $1.6B | $1.9B | $2.8B |
| Long-term debt | $2.5B | $2.5B | $2.5B | $2.5B | $4.0B |
| Total liabilities | $5.4B | $5.6B | $5.3B | $5.1B | $7.5B |
| Shareholders' equity | $729.0M | $388.0M | $492.0M | $482.0M | $252.0M |
Cash flow statement
Outflows are negative| FY2022 | FY2023 | FY2024 | FY2025 | FY2026 | |
|---|---|---|---|---|---|
| Net income | $471.0M | $161.0M | $292.0M | $824.0M | $601.0M |
| Depreciation & amortization | $224.0M | $236.0M | $235.0M | $219.0M | $247.0M |
| Stock-based compensation | $52.0M | $73.0M | $74.0M | $81.0M | $48.0M |
| Change in working capital | −$99.0M | $354.0M | −$241.0M | −$211.0M | $118.0M |
| Operating cash flow | $786.0M | $1.2B | $695.0M | $981.0M | $612.0M |
| Capital expenditure | −$251.0M | −$228.0M | −$212.0M | −$220.0M | −$207.0M |
| Free cash flow | $535.0M | $930.0M | $483.0M | $761.0M | $405.0M |
| Investing cash flow | −$229.0M | −$223.0M | −$175.0M | −$94.0M | −$2.3B |
| Net debt issued / repaid | −$83.0M | −$188.0M | −$45.0M | $0 | $2.6B |
| Buybacks | −$25.0M | $0 | $0 | −$332.0M | −$256.0M |
| Dividends paid | −$571.0M | −$583.0M | −$595.0M | −$602.0M | −$602.0M |
Ratio history
Margins on the fiscal-year (TTM at Q4) basis; multiples at each year end| FY2022 | FY2023 | FY2024 | FY2025 | FY2026 | |
|---|---|---|---|---|---|
| Gross margin | 35.5% | 39.3% | 42.8% | 45.1% | 42.3% |
| Operating margin | 10.2% | 11.6% | 13.0% | 16.7% | 24.7% |
| Net margin | 6.5% | 2.0% | 3.9% | 11.4% | 8.7% |
| FCF margin | 7.5% | 12.6% | 6.8% | 10.7% | 6.0% |
| ROE | 95.6% | 38.4% | 102.2% | 249.6% | 285.6% |
| ROIC | 16.2% | 20.9% | 22.4% | 29.9% | 23.1% |
| ROA | 7.4% | 2.5% | 4.8% | 14.3% | 8.8% |
| Debt / equity | 5.58 | 13.29 | 8.85 | 8.97 | 61.33 |
| Interest coverage | 7.3x | 3.3x | 4.9x | 12.0x | 7.1x |
| Current ratio | 0.97 | 0.95 | 1.03 | 0.84 | 0.66 |
| Revenue growth | −3.2% | +4.0% | −4.0% | +0.2% | −5.4% |
| EPS growth | −34.1% | −68.0% | +87.3% | +192.3% | −26.6% |
| P/E at year end | 33.5x | 121.9x | 57.8x | 18.0x | 19.9x |
| EV / EBITDA at year end | 19.8x | 35.9x | 25.7x | 12.4x | 14.6x |
| FCF yield at year end | 3.45% | 5.12% | 2.98% | 5.23% | 3.47% |
| Dividend payout | 123.6% | 391.3% | 212.5% | 74.3% | 102.6% |
Revenue by segment
| FY2022 | FY2023 | FY2024 | FY2025 | FY2026 | |
|---|---|---|---|---|---|
| Health and Wellness | $2.7B | $2.5B | $2.5B | $2.7B | $2.7B |
| Household | $2.0B | $2.1B | $1.9B | $2.0B | $1.8B |
| Lifestyle | $1.3B | $1.3B | $1.3B | $1.3B | $1.1B |
| International | $1.2B | $1.2B | $1.2B | $1.1B | $1.1B |
Revenue by region · FY2026
Street estimates by fiscal year
Next report 2026-11-02 · consensus EPS $1.08 · these are analysts' numbers, not ours| Fiscal year | Revenue (mean) | Revenue range | EPS (mean) | EPS range | Analysts | P/E on mean EPS |
|---|---|---|---|---|---|---|
| 2026 | $6.7B | $6.7B – $6.7B | $5.52 | $5.48 – $5.59 | 9 | 15.8x |
| 2027 | $7.6B | $7.6B – $7.7B | $5.72 | $5.50 – $5.78 | 11 | 15.2x |
| 2028 | $7.8B | $7.7B – $7.9B | $6.15 | $6.02 – $6.30 | 10 | 14.2x |
Reported vs expected, every quarter on file
| Reported | EPS expected | EPS actual | EPS surprise | Revenue expected | Revenue actual | Revenue surprise |
|---|---|---|---|---|---|---|
| 2026-08-03 | $1.64 | $1.66 | +1.2% | $1.9B | $1.9B | +1.7% |
| 2026-04-30 | $1.54 | $1.64 | +6.5% | $1.7B | $1.7B | +0.0% |
| 2026-02-03 | $1.43 | $1.39 | −2.8% | $1.6B | $1.7B | +2.0% |
| 2025-11-03 | $0.82 | $0.85 | +3.9% | $1.4B | $1.4B | +2.1% |
| 2025-07-31 | $2.20 | $2.87 | +30.5% | $1.9B | $2.0B | +3.1% |
| 2025-05-05 | $1.55 | $1.45 | −6.5% | $1.7B | $1.7B | −2.7% |
| 2025-02-03 | $1.39 | $1.55 | +11.5% | $1.8B | $1.7B | −4.3% |
| 2024-10-30 | $1.41 | $1.86 | +31.9% | $1.6B | $1.8B | +6.9% |
| 2024-08-01 | $1.56 | $1.82 | +16.7% | $1.9B | $1.9B | −2.3% |
| 2024-04-30 | $1.36 | $1.71 | +25.7% | $1.9B | $1.8B | −3.0% |
| 2024-02-01 | $1.08 | $2.16 | +100.0% | $1.8B | $2.0B | +10.3% |
| 2023-11-01 | $-0.20 | $0.49 | +345.0% | $1.3B | $1.4B | +6.0% |
| 2023-08-02 | $1.18 | $1.67 | +41.5% | $1.9B | $2.0B | +7.6% |
| 2023-05-02 | $1.20 | $1.51 | +25.8% | $1.8B | $1.9B | +5.3% |
| 2023-02-02 | $0.65 | $0.98 | +50.8% | $1.7B | $1.7B | +3.4% |
| 2022-11-01 | $0.73 | $0.93 | +27.4% | $1.7B | $1.7B | +2.8% |
| 2022-08-03 | $0.93 | $0.93 | 0.0% | $1.9B | $1.8B | −3.4% |
| 2022-05-02 | $0.97 | $1.31 | +35.1% | $1.8B | $1.8B | +0.8% |
| 2022-02-03 | $0.84 | $0.66 | −21.4% | $1.7B | $1.7B | +1.4% |
| 2021-11-01 | $1.03 | $1.21 | +17.5% | $1.7B | $1.8B | +7.1% |
| 2021-08-03 | $1.35 | $0.95 | −29.6% | $1.8B | $1.8B | 0.0% |
| 2021-04-30 | $1.47 | $1.62 | +10.2% | $1.9B | $1.8B | −4.4% |
| 2021-02-04 | $1.78 | $2.03 | +14.0% | $1.6B | $1.8B | +16.3% |
| 2020-11-02 | $2.32 | $3.22 | +38.8% | $1.8B | $1.9B | +8.9% |
Off-exchange (dark pool) volume, weekly
FINRA ATS, $ billions · through the week of 2026-08-31 (FINRA publishes with a delay)| Week of | Notional | Shares | Trades |
|---|---|---|---|
| 2026-08-31 | $385.6M | 4,013,732 | 99,129 |
| 2026-08-24 | $258.1M | 2,457,694 | 71,069 |
| 2026-08-17 | $383.9M | 3,598,178 | 78,363 |
| 2026-08-10 | $411.5M | 3,865,222 | 87,445 |
| 2026-08-03 | $506.5M | 4,944,852 | 101,539 |
| 2026-07-27 | $330.3M | 3,370,371 | 83,379 |
Short-sale share of off-exchange volume
daily 20-day average| Date | Short share | Short volume | Total volume |
|---|---|---|---|
| 2026-10-15 | 51.2% | 760,438 | 1,485,236 |
| 2026-10-14 | 68.6% | 642,209 | 935,527 |
| 2026-10-13 | 67.1% | 575,829 | 857,588 |
| 2026-10-12 | 66.0% | 561,475 | 850,638 |
| 2026-10-09 | 63.2% | 429,280 | 678,833 |
| 2026-10-08 | 54.8% | 502,595 | 916,774 |
| 2026-10-07 | 70.8% | 665,669 | 939,961 |
| 2026-10-06 | 66.4% | 875,982 | 1,319,816 |
| 2026-10-05 | 65.8% | 797,201 | 1,210,930 |
| 2026-10-02 | 60.7% | 635,517 | 1,047,420 |
Seasonality
Average return by calendar month| Month | Avg return | Up years | Years |
|---|---|---|---|
| Jan | +1.0% | 55% | 20 |
| Feb | +0.1% | 55% | 20 |
| Mar | +0.5% | 71% | 21 |
| Apr | +0.6% | 50% | 20 |
| May | −0.8% | 45% | 20 |
| Jun | +0.5% | 55% | 20 |
| Jul | +1.8% | 60% | 20 |
| Aug | +1.1% | 50% | 20 |
| Sep | −1.1% | 50% | 20 |
| Oct | +1.0% | 50% | 20 |
| Nov | +1.9% | 55% | 20 |
| Dec | +0.1% | 60% | 20 |
Indicators
as of 2026-10-16Moving averages and bands
level (price vs level)About The Clorox Company
The Clorox Company is a global manufacturer and marketer of both consumer and professional products, operating through four distinct segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness division offers a range of cleaning solutions, including laundry additives and home care items under brand names such as Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409. It also supplies professional cleaning and disinfecting products via the CloroxPro and Clorox Healthcare brands, alongside professional food service goods from Hidden Valley. Additionally, this segment provides vitamins, minerals, and supplements (VMS) within the United States, marketed under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light labels. Dedicated to the U.S. market, the Household segment features cat litter products from Fresh Step and Scoop Away, food storage bags and wraps under the Glad brand, and grilling essentials like Kingsford charcoal. The Lifestyle segment, also primarily serving the U.S., encompasses dressings, dips, seasonings, and sauces, predominantly from Hidden Valley; natural personal care items offered by Burt's Bees; and water-filtration systems from Brita. Internationally, the International segment distributes a broad portfolio of products including laundry additives, home care items, water-filtration systems, digestive health products, grilling supplies, cat litter, various food items, bags and wraps, natural personal care products, and professional cleaning and disinfecting solutions. Key international brands include Clorox, Ayudin, Clorinda, Poett, Pine-Sol, Glad, Brita, RenewLife, Ever Clean, and Burt's Bees. Clorox's extensive product line reaches customers through a diverse array of channels. These include major retailers, grocery stores, warehouse clubs, discount outlets, home hardware centers, pharmacies, pet stores, military exchanges, both company-owned and third-party e-commerce platforms, distributors, and a direct sales force. Established in 1913, the company's corporate headquarters are situated in Oakland, California.
Key executives
| Name | Title | Pay | Born |
|---|---|---|---|
| Linda Rendle | Chief Executive Officer & Chairman | $3.3M | 1978 |
| Nina Barton | Executive VP and Chief Growth & Strategy Officer | $2.1M | 1974 |
| Luc Bellet | Executive Vice President & Chief Financial Officer | $1.4M | 1979 |
| Kirsten Marriner | Executive Vice President & Chief Administrative Officer | $1.3M | 1973 |
| Chris T. Hyder | Executive VP & COO | $1.3M | 1975 |
| Angela C. Hilt | Executive Vice President, Chief Legal & External Affairs Officer and Corporate Secretary | $1.3M | 1972 |
| Erbie L. Foster Jr. | Chief Diversity Officer | — | — |
| Laura E. Peck | Vice President, Chief Accounting Officer & Corporate Controller | — | 1977 |
Executive pay, latest proxy
| Executive | Year | Salary | Stock awards | Incentive | Total |
|---|---|---|---|---|---|
| Linda Rendle Chair and Chief Executive Officer (CEO) | 2026 | $1.3M | $10.7M | $1.2M | $14.0M |
| Luc Bellet EVP and Chief Financial Officer (CFO) | 2026 | $751,923 | $6.3M | $410,400 | $7.7M |
| Chris Hyder EVP and Chief Operating Officer | 2026 | $713,462 | $6.2M | $390,457 | $7.6M |
| Kirsten Marriner EVP and Chief Administrative Officer | 2026 | $744,231 | $4.9M | $364,500 | $6.2M |
| Angela Hilt EVP and Chief Legal & External Affairs Officer and Corporate Secretary | 2026 | $746,538 | $4.7M | $344,250 | $6.0M |
Employees
Dividends
| Ex-date | Amount | Paid |
|---|---|---|
| 2026-10-28 | $1.25 | 2026-11-13 |
| 2026-08-12 | $1.25 | 2026-08-28 |
| 2026-04-22 | $1.24 | 2026-05-08 |
| 2026-01-28 | $1.24 | 2026-02-13 |
| 2025-10-22 | $1.24 | 2025-11-06 |
| 2025-08-13 | $1.24 | 2025-08-29 |
| 2025-04-23 | $1.22 | 2025-05-09 |
| 2025-01-29 | $1.22 | 2025-02-14 |